Literature DB >> 7798298

Aberrations of the APC gene in primary breast carcinoma.

M Kashiwaba1, G Tamura, M Ishida.   

Abstract

Aberrations of the APC gene, which plays an important role in the genesis of familial adenomatous polyposis and colorectal carcinoma, were investigated in 31 surgical specimens of primary breast carcinoma. These studies utilized the polymerase chain reaction followed by restriction-fragment-length polymorphism and single-strand-conformation polymorphism analyses combined with tumor cell enrichment by cell sorting. Loss of heterozygosity at the APC locus was detected in 8 (38%) of 21 informative cases, but only 2 (6%) of 31 tumors carried a mutated APC gene. Direct DNA sequencing analysis confirmed mutations at codon 1081 (AGC to ATC) resulting in an amino acid substitution of serine for isoleucine, and at codon 1096 (CAG to CAT) resulting in a substitution of glutamine for histidine. There were no significant correlations between the loss of heterozygosity or mutation at the APC locus and any clinicopathological characteristics. Our present observations suggest that the mutations of the APC gene may play an important role in the genesis of certain breast carcinomas, and that another tumor-suppressor gene, which is the true target of frequent loss of heterozygosity, may exist near the APC gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7798298     DOI: 10.1007/bf01194271

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  42 in total

1.  Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients.

Authors:  Y Miyoshi; H Ando; H Nagase; I Nishisho; A Horii; Y Miki; T Mori; J Utsunomiya; S Baba; G Petersen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

2.  The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression.

Authors:  A Borg; Q X Zhang; P Alm; H Olsson; G Sellberg
Journal:  Cancer Res       Date:  1992-05-15       Impact factor: 12.701

3.  Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma.

Authors:  R Morita; S Saito; J Ishikawa; O Ogawa; O Yoshida; K Yamakawa; Y Nakamura
Journal:  Cancer Res       Date:  1991-11-01       Impact factor: 12.701

4.  Accumulation of genetic alterations and progression of primary breast cancer.

Authors:  T Sato; F Akiyama; G Sakamoto; F Kasumi; Y Nakamura
Journal:  Cancer Res       Date:  1991-11-01       Impact factor: 12.701

5.  p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.

Authors:  S J Baker; A C Preisinger; J M Jessup; C Paraskeva; S Markowitz; J K Willson; S Hamilton; B Vogelstein
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

6.  APC mutations occur early during colorectal tumorigenesis.

Authors:  S M Powell; N Zilz; Y Beazer-Barclay; T M Bryan; S R Hamilton; S N Thibodeau; B Vogelstein; K W Kinzler
Journal:  Nature       Date:  1992-09-17       Impact factor: 49.962

7.  Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis.

Authors:  B D Greenwald; N Harpaz; J Yin; Y Huang; Y Tong; V L Brown; T McDaniel; C Newkirk; J H Resau; S J Meltzer
Journal:  Cancer Res       Date:  1992-02-01       Impact factor: 12.701

8.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

9.  Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.

Authors:  T Sato; A Tanigami; K Yamakawa; F Akiyama; F Kasumi; G Sakamoto; Y Nakamura
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

10.  Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level.

Authors:  J Mackay; P A Elder; D J Porteous; C M Steel; R A Hawkins; J J Going; U Chetty
Journal:  Br J Cancer       Date:  1988-12       Impact factor: 7.640

View more
  12 in total

1.  Genome-wide analysis of interferon regulatory factor I binding in primary human monocytes.

Authors:  Lihua Shi; Juan C Perin; Jeremy Leipzig; Zhe Zhang; Kathleen E Sullivan
Journal:  Gene       Date:  2011-07-19       Impact factor: 3.688

2.  APC mutations in sporadic medulloblastomas.

Authors:  H Huang; B M Mahler-Araujo; A Sankila; L Chimelli; Y Yonekawa; P Kleihues; H Ohgaki
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

Review 3.  Transgenic models to study actions of prolactin in mammary neoplasia.

Authors:  Lisa M Arendt; Linda A Schuler
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

Review 4.  Epigenetic gene silencing in the Wnt pathway in breast cancer.

Authors:  George J Klarmann; Amy Decker; William L Farrar
Journal:  Epigenetics       Date:  2008-03-12       Impact factor: 4.528

Review 5.  Wnt-cadherin connections in normal and neoplastic mammary epithelium.

Authors:  Valerie Meniel; Alan R Clarke
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-10       Impact factor: 2.673

6.  Activation status of Wnt/ß-catenin signaling in normal and neoplastic breast tissues: relationship to HER2/neu expression in human and mouse.

Authors:  Sara Khalil; Grace A Tan; Dilip D Giri; Xi Kathy Zhou; Louise R Howe
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

Review 7.  Key signaling nodes in mammary gland development and cancer: β-catenin.

Authors:  Angela Incassati; Anupama Chandramouli; Rachel Eelkema; Pamela Cowin
Journal:  Breast Cancer Res       Date:  2010-11-03       Impact factor: 6.466

8.  Association of the I1307K APC mutation with hereditary and sporadic breast/ovarian cancer: more questions than answers.

Authors:  R Gershoni-Baruch; Y Patael; A Figer; L Kasinetz; E Kadouri; R Bruchim Bar Sade; E Friedman
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640

9.  Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers.

Authors:  Z Jin; G Tamura; T Tsuchiya; K Sakata; M Kashiwaba; M Osakabe; T Motoyama
Journal:  Br J Cancer       Date:  2001-07-06       Impact factor: 7.640

10.  Analysing the mutational status of adenomatous polyposis coli (APC) gene in breast cancer.

Authors:  Ya-Sian Chang; Chien-Yu Lin; Shu-Fen Yang; Cheng-Mao Ho; Jan-Gowth Chang
Journal:  Cancer Cell Int       Date:  2016-03-28       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.